DIAGNOSTIC FEATURES OF HYPERCOAGULATION SYNDROME IN TYPE 2 DIABETES: CLINICAL LAB INSIGHTS
Keywords:
Diabetes Mellitus, hypercoagulation, syndrome, D-DimerAbstract
Patients with Type 2 Diabetes Mellitus (T2DM) are at an increased risk of developing hypercoagulation syndrome, a condition where blood clots form excessively and abnormally. Clinical laboratory diagnostics play a vital role in identifying and managing this syndrome in individuals with T2DM. Here are the key features of clinical laboratory diagnostics concerning hypercoagulation syndrome in these patients:
References
Abduvaliev A.R., Inoyatova F.Kh., Mirkomilov E.M. A method of inhibiting t-helper 2 cells to prevent lung fibrosis that develops as a result of atypical pneumonia in COVID-19 // Proceeding of Global Congress of Contemporary Study- A Multidisciplinary International Scientific Conference Hosted from Pune, M.S. India.- P.182-187. www.econferenceglobe.com.
Sushentseva N. N., Popov O. S., Apalko S. V. et al. Biobank COVID-19: features of the cytokine profile / / Cardiovascular therapy and prevention. 2020, vol.19 (6), pp. 191-195..191-195.
Xia H., Bodempudi V., Benyumov A. et al. Identification of a celloforigin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis Am. J. Pathol. 2014;184: 1369–1383.
Maher T.M. Beyond the diagnosis of idiopathic pulmonary fibrosis: the growing role of systems biology and stratified medicine. Curr. Opin. Pulm. Med. 2013; 19: 460–465.
Thorax. The pulmonary physician in critical care 6: The pathogenesis of ALI/ARDS/ G.J.Bellingan // Thorax 2002 Jun; 57(6):540-6./ doi:10.1136/ thorax. 57.6.540.
Ниёзова, Ш. С., Турсунов, Д. Х., Алимов, С. М., Ахматова, К. А., & Султонова, Д. Ш. (2023). Covid-19 билан касалланган бeморлар қон зардобида оқсил алмашинуви кўрсаткичларининг тахлили (Doctoral dissertation, KLINIK LABORATOR DIAGNOSTIKADA INNOVATSION TEXNOLOGIYALARDAN FOYDALANISH, MUAMMOLAR VA YECHIMLAR).
